Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Similarities and distinctions in the mode of action of different classes of antioestrogens.

Literature DB >> 10808193

Similarities and distinctions in the mode of action of different classes of antioestrogens.

A E Wakeling¹.

Abstract

Mesh：

Substances：

Year: 2000 PMID： 10808193 DOI： 10.1677/erc.0.0070017

Source DB: PubMed Journal: Endocr Relat Cancer ISSN： 1351-0088 Impact factor: 5.678

Keyword Cloud
Cited

× No keyword cloud information.

34 in total

Review 1. Mechanisms of resistance to hormonal treatment in breast cancer.

Authors: P Eroles; A Bosch; B Bermejo; A Lluch
Journal: Clin Transl Oncol Date: 2010-04 Impact factor: 3.405

2. An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells.

Authors: Xiaohua Gao; Linda Yu; Lysandra Castro; Alicia B Moore; Tonia Hermon; Carl Bortner; Maria Sifre; Darlene Dixon
Journal: Toxicol Lett Date: 2010-03-15 Impact factor: 4.372

Review 3. The sequential use of endocrine treatment for advanced breast cancer: where are we?

Authors: C Barrios; J F Forbes; W Jonat; P Conte; W Gradishar; A Buzdar; K Gelmon; M Gnant; J Bonneterre; M Toi; C Hudis; J F R Robertson
Journal: Ann Oncol Date: 2012-02-08 Impact factor: 32.976

4. Proteomics analysis of the estrogen receptor alpha receptosome.

Authors: Ivan Nalvarte; Thomas Schwend; Jan-Ake Gustafsson
Journal: Mol Cell Proteomics Date: 2010-03-27 Impact factor: 5.911

Review 5. Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.

Authors: Virginia G Kaklamani; William J Gradishar
Journal: Oncologist Date: 2017-03-17

Similarities and distinctions in the mode of action of different classes of antioestrogens.

Review 1. Mechanisms of resistance to hormonal treatment in breast cancer.

2. An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells.

Review 3. The sequential use of endocrine treatment for advanced breast cancer: where are we?

4. Proteomics analysis of the estrogen receptor alpha receptosome.

Review 5. Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.

Review 6. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.

7. Icam5 Expression Exhibits Sex Differences in the Neonatal Pituitary and Is Regulated by Estradiol and Bisphenol A.

8. Shugan Liangxue Decoction () Down-Regulates Estrogen Receptor α Expression in Breast Cancer Cells.

9. 17beta-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes.

Review 10. Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.